Design of MHC class II (DR4) ligands using conformationally restricted imino acids at p3 and p5
- 1 August 1996
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (16), 1931-1936
- https://doi.org/10.1016/0960-894x(96)00348-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.The Journal of Immunology, 1995
- Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401Arthritis & Rheumatism, 1995
- Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.The Journal of Experimental Medicine, 1995
- Chapter 21. The T Cell – Antigen Presenting Cell Interaction as a Site for Immunosuppressive InterventionsPublished by Elsevier BV ,1995
- Renin inhibitor SC-51106 complexed with human renin: Discovery of a new binding site adjacent to P3Bioorganic & Medicinal Chemistry, 1994
- The Molecular Basis of Susceptibility to Rheumatoid ArthritisAdvances in Immunology, 1994
- Design and synthesis of peptidomimetic inhibitors of HIV-1 protease and renin. Evidence for improved transportJournal of Medicinal Chemistry, 1994